References
-
1
Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, Bernardi M, Gasbarrini G. GHB Study Group .
An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects.
Alcohol Alcoholism.
1996;
31
341-345
-
2
Catalano MC, Glass JM, Catalano G, Burrows SL, Lynn WA, Weitzner BS.
Gamma butyrolactone (GBL) withdrawal syndromes.
Psychosomatics.
2001;
42
83-88
-
3
DRUGS – die Partydrogeninfo .
, Internet version from 11-3-2007.
http://www.eve-rave.net/download.sp?file=bericht108.pdf
-
4
Dyer JO, Roth B, Hyma BA.
Gamma-hydroxybutyrate withdrawal syndrome.
Ann Emerg Med.
2001;
37
147-153
-
5
Freese TE, Miotto K, Reback CJ.
The effects and consequences of selected club drugs.
J Subst Abuse Treat.
2002;
23
151-156
-
6
Hahne N, Weinmann W, Nebel BW.
Hydroxybutyrate intoxication.
Anaesthesist.
2004;
53
950-954
-
7
Hardmeyer M, Eichhorn M, Stoppe G.
Agitation and γ-hydroxybutyrate.
Nervenarzt.
2006;
77
1111-1114
-
8
Hutto B, Fairchild A, Bright R.
Hydroxybutyrate-withdrawal and chloral hydrate. Letter to the editor.
Am J Psychiatry.
2000;
157
1706
-
9
Landeskriminalamt Baden-Württemberg .
G.H.B. “Liquid Ecstasy”.
http://www.polizei-bw.de/lka/praevention/downloads/drogen-stoff/ghb.pdf
-
10
Liechti ME, Mathys J.
Coma in a 21-year-old party attendant.
Internist.
2003;
44
215-221
-
11
Martens F.
Glückstropfen.
Notarzt.
2004;
20
215-216
-
12
Maxwell JC.
The response to club drug use.
Curr Opin Psychiatry.
2003;
16
279-289
-
13
MacDonough M, Kennedy N, Glasper A, Bearn J.
Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
Drug Alcohol Depend.
2004;
75
3-9
-
14
Rodgers J, Ashton CH, Gilvarry E, Young AH.
Liquid ecstasy: a new kid on the dance floor.
Br J Psychiatry.
2004;
184
104-106
-
15
Sivilotti ML, Burns MJ, Aaron CK, Greenberg MJ.
Pentobarbital for severe gamma-butyrolactone withdrawal.
Ann Emerg Med.
2001;
38
660-665
-
16
Snead OC, Gibson KM.
Drug therapy: (gamma)-hydroxybutyric acid.
N Engl J Med.
2005;
352
2721-2732
-
17
Teter CJ, Guthrie SK.
A comprehensive review of MDMA and GHB: Two common club drugs.
Pharmacotherapy.
2001;
21
1486-1513
-
18
Trendelenburg G, Ströhle A.
Hydroxybutyrate – a neurotransmitter, medicine, and drug.
Nervenarzt.
2005;
76
832-838
-
19
Walloch S, Haasen C, Püschel K, Heinemann A.
Drug emergencies in Hamburg: an analysis based on the protocols of rescue operations involving emergency doctors 1997–2004.
Suchttherapie.
2007;
8
115-118
Correspondence
Dr. med. F. Hohl-Radke
Klinik für Psychiatrie
Psychotherapie und Psychosomatik
Vivantes Klinikum Spandau
Neue Bergstrasse 6
13585 Berlin
Germany
Phone: +49/30/13013 30 35
Fax: +49/30/13013 30 04
Email: Felix.Hohl-Radke@vivantes.de
